The WVU Cancer Institute is one of several sites nationwide that participated in a groundbreaking clinical research study of a novel drug proven very effective in the treatment of pediatric and adult cancers that carry a specific genetic mutation. Patrick Ma, MD, principal investigator of the Cancer Institute study, co-authored an article about the drug in the New England Journal of Medicine.